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Studies suggest that endogenous field effects may play a role in neuronal oscillations and
communication. Non-invasive transcranial electrical stimulation with low-intensity currents
can also have direct effects on the underlying cortex as well as distant network effects.
While Parkinson’s disease (PD) is amenable to invasive neuromodulation in the basal
ganglia by deep brain stimulation (DBS), techniques of non-invasive neuromodulation
like transcranial direct current stimulation (tDCS) and transcranial alternating current
stimulation (tACS) are being investigated as possible therapies. tDCS and tACS have the
potential to influence the abnormal cortical-subcortical network activity that occurs in PD
through sub-threshold changes in cortical excitability or through entrainment or disruption
of ongoing rhythmic cortical activity. This may allow for the targeting of specific features of
the disease involving abnormal oscillatory activity, as well as the enhancement of potential
cortical compensation for basal ganglia dysfunction and modulation of cortical plasticity in
neurorehabilitation. However, little is currently known about how cortical stimulation will
affect subcortical structures, the size of any effect, and the factors of stimulation that will
influence these effects.
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INTRODUCTION
Are transcranial direct current stimulation (tDCS) and transcra-
nial alternating current stimulation (tACS) potential treatment
modalities for Parkinson’s disease (PD)?
While the foremost treatment for PD continues to be
dopaminergic medications, invasive neuromodulation through
deep brain stimulation (DBS) has become a mainstay of therapy
in selected patients (Okun, 2012). As in a variety of other
neurological disorders (Rothwell, 2012; Schulz et al., 2013),
techniques of non-invasive neuromodulation are also being
investigated as possible treatment options for PD (Cantello,
2002; Fregni et al., 2005; Edwards et al., 2008; Wu et al.,
2008; Lefaucheur, 2009). However, PD is relatively unique
amongst these diseases in that the targeted network involves
cortical-subcortical activity rather than just cortical activity. This
mini-review discusses the use of non-invasive applied electrical
fields in PD and considers their potential to influence cortical
oscillations and modulate dysfunctional cortical-subcortical
networks through the application of weak exogenous fields.
A RATIONALE FOR TRANSCRANIAL ELECTRICAL
STIMULATION IN THE TREATMENT OF PARKINSON’S
DISEASE
Although classically considered a disease of the basal ganglia,
functional imaging and EEG studies have shown altered cortical
activity in the supplementary motor area (SMA), dorsolateral
prefrontal cortex (DLPFC), and primary motor cortex (M1) in
patients with PD (Priori and Lefaucheur, 2007). Moreover, syn-
chronization of oscillatory activity in themotor cortices at specific
frequencies is believed to be important in normal motor control
(Joundi et al., 2012), and excessive oscillatory activity and abnor-
mal synchronization in the beta band may play a role in the mani-
festation of PD symptoms (Eusebio and Brown, 2009; Shimamoto
et al., 2013). Though the relationship between beta oscillations
and PD remains poorly understood, it is rooted in the observa-
tions of enhanced beta frequency oscillations in the basal ganglia
in PD that are correlated with clinical symptoms and improve-
ment from dopaminergic medications, as well as a worsening of
motor symptoms that can be seen by inducing beta oscillations in
subthalamic nucleus (STN) using DBS (Stein and Bar-Gad, 2013).
Recent studies have suggested that this activity might be cortical
in origin, with hyperactivity of the STN occurring secondary to
abnormal motor cortical activity transmitted via the hyperdirect
pathway (Litvak et al., 2011; Crowell et al., 2012). Further, the
clinical efficacy of STN DBS in PD may involve antidromic
effects upon the motor cortex (Gradinaru et al., 2009), and high
frequency DBS has been shown to decrease beta frequency power
in the cortical origin of the hyperdirect pathway that is coherent
with beta frequency activity in the STN (Whitmer et al., 2012).
Techniques of non-invasive neuromodulation such as
tDCS and tACS have the potential to influence the abnormal
cortical-subcortical network activity that occurs in PD (Figure 1).
tDCS is believed to exert its primary influence on the CNS
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FIGURE 1 | Schematic of the pathways of the basal
ganglia-thalamocortical network that non-invasive transcranial
electrical stimulation could potentially influence. Unfilled arrows are
excitatory connections. Filled arrows are inhibitory connections. D1 = D1
dopaminergic receptors; D2 = D2 dopaminergic receptors; GABA =
γ -Aminobutyric acid (GABA)-ergic; Glu = glutaminergic; Gpe = external
segment of the globus pallidus; Gpi = internal segment of the globus
pallidus; SNc = substantia nigra pars compacta; SNr = substantia nigra pars
reticulata; STN = subthalamic nucleus; Thal = thalamus. Modified with
permission from Hess et al. (2013).
through extracellular field effects upon membrane potentials
(Paulus, 2011) in both a site and polarity specific manner
(Zaghi et al., 2010). In general, anodal stimulation increases
cortical excitability, while cathodal stimulation decreases it
(Nitsche and Paulus, 2000, 2001). Longer-acting effects are
likely mediated by separate polarity-specific effects on synaptic
plasticity (Liebetanz et al., 2002; Fritsch et al., 2010; Stagg
and Nitsche, 2011). In addition to modulating local cortical
excitability, neuroimaging studies have demonstrated the ability
of tDCS to influence regional cerebral blood flow (rCBF) and
resting-state functional connectivity in distant but anatomically
and/or functionally connected areas (Lang et al., 2005; Zaghi
et al., 2010; Keeser et al., 2011). Thus tDCS could potentially
ameliorate PD symptomatology through the induction of sub-
threshold changes in excitability in key cortical nodes of the basal
ganglia-thalamocortical pathway or produce long-term effects on
synaptic plasticity. The putative mechanism of action of tACS is
less clear, but may include entrainment or disruption of ongoing
rhythmic cortical activity (Zaghi et al., 2010). This could make
tACS an ideal modality to interfere with the abnormal oscillatory
activity that occurs in the basal ganglia-thalamocortical network
in PD (Brittain et al., 2013).
tDCS IN PARKINSON’S DISEASE
The study of the therapeutic potential of tDCS in PD is still
largely preliminary, yet with some promising findings (Rothwell,
2012). In animal models, cathodal tDCS increased extracellular
dopamine levels as measured by striatal microdialysis in healthy
rats (Tanaka et al., 2013), and anodal tDCS ofM1 improvedmotor
function in the 6-hydroxydopamine rat model of PD (Li et al.,
2011). In patients with PD, a single session of sham-controlled
anodal tDCS of M1 yielded improvements in motor function that
were different from sham stimulation (Fregni et al., 2006). One
randomized, double-blind, sham-controlled trial examined the
effects of tDCS in PD (Benninger et al., 2010). Subjects underwent
eight sessions of tDCS (n = 13) or sham stimulation (n = 12)
while on medication, with stimulation in the tDCS group alter-
nating between the premotor/motor area and prefrontal cortex
stimulation. tDCS decreased walking time (the primary outcome)
compared to sham one day after stimulation, but only when
tested off medications and after exclusion of an outlier in the
sham group. Though motor Unified Parkinson’s Disease Rating
Scale (UPDRS) and reaction time changes did not differ between
groups, upper extremity bradykinesia was significantly improved
at all evaluations periods up to three months after stimulation.
In addition to motor symptoms, a wide variety of non-motor
symptoms occur in PD that are not responsive to levodopa
therapy and could potentially be treated with tDCS (Wu et al.,
2008). Left DLPFC anodal stimulation has been shown to improve
working memory in PD patients (Boggio et al., 2006), and anodal
DLPFC tDCS improved phonemic fluency and enhanced fMRI
measures of functional connectivity in verbal fluency related
networks (Pereira et al., 2013).
tACS IN PARKINSON’S DISEASE
As in tDCS, the literature related to PD using tACS is sparse,
though intriguing. tACS at varying frequencies was shown to
modulate the rate of force development and peak force in hand-
grip response to a go/no-go task (Joundi et al., 2012), and tACS
administered in the beta band (20 Hz) to M1 slowed voluntary
movement speed in healthy subjects (Pogosyan et al., 2009).While
in one study (Shill et al., 2011) tACS over the forehead and mas-
toids did not significantly influence off medication UPDRS scores
in early PD patients, a recent study achieved a reduction in tremor
amplitude of up to 53% using tACS over the contralateral M1 in
patients with tremor-dominant PD (Brittain et al., 2013). In this
study, tACS at tremor frequency, double tremor frequency, and
sham (30 seconds of stimulation) was applied in random order
to 12 patients over the transcranial magnetic simulation (TMS)-
demonstrated motor hot spot for the muscles most involved with
tremor. Stimulation was first allowed to drift in and out of phase
with tremor to determine the most effective phase relationship
in reducing tremor. In a subset of five patients, stimulation at
tremor frequency was given for 30 seconds, during which tremor
frequency and the phase relationship between tremor and stim-
ulation was monitored and adjusted in real time. Resting tremor
amplitudewas reduced by an average of 42%. Further, stimulation
did not interfere with performance on pegboard tasks, suggesting
that normal motor activity would likely not be affected.
CONCLUSIONS
The application of non-invasive applied electric fields provides a
potential window through which the dysfunctional subcortical-
cortical networks in PD can be accessed and influenced. However,
it remains largely speculative how cortical stimulation will affect
subcortical structures, what the effect size will be, and the factors
of stimulation that will influence these effects. Given the progres-
sive neurodegenerative nature of the disease and the increasing
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recognition of the full range of symptoms associated with it,
the utility of these techniques may be more as adjuncts to other
therapies (Chen, 2010). This being said, the ease of use and low
cost of transcranial electrical stimulation makes its development
for possible clinical uses appealing (Brunoni et al., 2013). In
addition to modulating basal ganglia-thalamocortical network
activity, tDCS and tACs may also be useful in promoting cortical
compensation for basal ganglia network dysfunction (Fregni et al.,
2006) and amplifying cortical plasticity during physical therapy
and neurorehabilitation (Chen, 2010; Block and Celnik, 2012).
tDCS has also already shown promise in the treatment of non-
motor cognitive symptoms in PD, for which current therapies are
quite limited when compared to therapies for motor symptoms
(Boggio et al., 2006; Wu et al., 2008; Pereira et al., 2013).
A better understanding of the mechanisms by which non-
invasive electrical stimulation affect neural networks would
likely streamline the discovery of any potential therapeutic
applications in PD. Yet as we have seen with DBS in PD, our
mechanistic understanding can sometimes lag behind successful
therapeutic implementation. Further studies will help to clarify
factors such as the optimal montages, sites, and intervals of
stimulation (Paulus, 2011), as well as potential interactions
with levodopa and other pharmacologic agents (Chaieb et al.,
2012).
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